Antipsychotic use and psychiatric disorders in COVID-19.
作者信息
Ferraris Augusto, Angriman Federico, Szmulewicz Alejandro G
机构信息
School of Medicine, University of Buenos Aries, Buenos Aires C111 3AAD, Argentina.
Institute for Health Policy, Management & Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
出版信息
Lancet Healthy Longev. 2021 Feb;2(2):e64. doi: 10.1016/S2666-7568(20)30063-5. Epub 2021 Feb 3.
Abstract
摘要
相似文献
1
Antipsychotic use and psychiatric disorders in COVID-19.新冠疫情中抗精神病药物的使用与精神疾病
Lancet Healthy Longev. 2021 Feb;2(2):e64. doi: 10.1016/S2666-7568(20)30063-5. Epub 2021 Feb 3.
2
Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? - Authors' reply.抗精神病药物的使用是否介导了精神疾病对COVID-19的影响？——作者回复。
Lancet Healthy Longev. 2021 Feb;2(2):e65. doi: 10.1016/S2666-7568(21)00007-6. Epub 2021 Feb 3.
3
Psychiatric disorders and risk of infections: early lessons from COVID-19.精神疾病与感染风险：来自新冠疫情的早期教训
Lancet Healthy Longev. 2020 Nov;1(2):e51-e52. doi: 10.1016/S2666-7568(20)30020-9. Epub 2020 Nov 9.
4
The big issue.重大问题。
Ment Health Today. 2009 Jun:13-5.
5
Antipsychotic polypharmacy in psychiatric practice: is it really doomed?精神科临床中的抗精神病药物联合使用：它真的注定失败吗？
Australas Psychiatry. 2017 Apr;25(2):200-201. doi: 10.1177/1039856216671652.
6
7
Trends in antipsychotic drug use by very young, privately insured children.抗精神病药物在非常年幼的、私人保险的儿童中的使用趋势。
J Am Acad Child Adolesc Psychiatry. 2010 Jan;49(1):13-23. doi: 10.1097/00004583-201001000-00005.
8
Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.非典型抗精神病药物在精神分裂症及其他精神障碍治疗中的应用。第二部分：特殊考量。
J Clin Psychiatry. 1998 Jun;59(6):322-8. doi: 10.4088/jcp.v59n0610.
9
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].[氯丙嗪在新冠病毒肺炎治疗中的重新应用：恢复研究]
Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29.
10
Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study.诊断后使用抗精神病药与癌症死亡率：基于人群的队列研究。
BMC Cancer. 2020 Aug 24;20(1):804. doi: 10.1186/s12885-020-07320-3.
引用本文的文献
1
Adherence to Antipsychotics, COVID-19 and Stigma: A Rainbow After the Storm?抗精神病药物的依从性、COVID-19与污名化：暴风雨后的彩虹？
Actas Esp Psiquiatr. 2025 May;53(3):616-620. doi: 10.62641/aep.v53i3.1813.
2
Antipsychotics, COVID-19, and Secondary Healthcare Databases: Revisiting the Pandemic.抗精神病药物、新冠疫情与二级医疗保健数据库：重访大流行
Int J Neuropsychopharmacol. 2024 Jul 1;27(7). doi: 10.1093/ijnp/pyae026.
3
COVID-19 and Antipsychotic Therapy: Unraveling the Thrombosis Risk.新型冠状病毒肺炎（COVID-19）与抗精神病药物治疗：血栓风险的探索。
Int J Mol Sci. 2024 Jan 9;25(2):818. doi: 10.3390/ijms25020818.
4
An overall protective effect of antipsychotic drugs against COVID-19 seems implausible.抗精神病药物对新冠病毒疾病具有全面保护作用，这似乎不太可信。
Schizophr Res. 2022 May;243:486-488. doi: 10.1016/j.schres.2021.12.020. Epub 2021 Dec 22.
5
Can antipsychotic use protect from COVID-19?使用抗精神病药物能预防新型冠状病毒肺炎吗？
Schizophr Res. 2021 Oct;236:1-2. doi: 10.1016/j.schres.2021.07.035. Epub 2021 Jul 30.
本文引用的文献
1
Antipsychotic Use and Bloodstream Infections Among Adult Patients With Chronic Obstructive Pulmonary Disease: A Cohort Study.抗精神病药使用与慢性阻塞性肺疾病成年患者血流感染：一项队列研究。
J Clin Psychiatry. 2021 Apr 13;82(3):20m13516. doi: 10.4088/JCP.20m13516.
2
Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis.大流行前的精神障碍与 COVID-19 风险：英国生物银行队列研究。
Lancet Healthy Longev. 2020 Nov;1(2):e69-e79. doi: 10.1016/S2666-7568(20)30013-1. Epub 2020 Oct 26.
3
Clozapine treatment and risk of COVID-19 infection: retrospective cohort study.氯氮平治疗与 COVID-19 感染风险：回顾性队列研究。
Br J Psychiatry. 2021 Jul;219(1):368-374. doi: 10.1192/bjp.2020.151.
4
Antipsychotic drug use and pneumonia: Systematic review and meta-analysis.抗精神病药物的使用与肺炎：系统评价和荟萃分析。
J Psychopharmacol. 2018 Nov;32(11):1167-1181. doi: 10.1177/0269881118795333. Epub 2018 Oct 18.
5
Association Between Urinary Tract Infections and Antipsychotic Drug Use in Older Adults.老年人尿路感染与抗精神病药物使用之间的关联
J Clin Psychopharmacol. 2018 Aug;38(4):296-301. doi: 10.1097/JCP.0000000000000895.
Zotero 插件